Lantheus Holdings (LNTH) Other Working Capital Changes (2014 - 2026)
Lantheus Holdings (LNTH) posted quarterly Other Working Capital Changes of $244000.0 for Q1 2026, down 53.79% year-over-year from $528000.0 in Q1 2025, and up 126.01% quarter-over-quarter from -$938000.0 in Q4 2025.
Lantheus Holdings (LNTH) Other Working Capital Changes (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Other Working Capital Changes for 10 consecutive years, with $84000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 53.79% year-over-year to $244000.0; the TTM figure through Mar 2026 stood at $5.1 million (up 4514.41% YoY), while the FY2025 annual figure was $5.4 million, up 221.76% from the prior year.
- Other Working Capital Changes declined to $84000.0 in Q1 2026 per LNTH's latest filing, from $3.0 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.0 million in Q4 2025 and bottomed at -$11.9 million in Q4 2022.
- Historically, Other Working Capital Changes has averaged -$589058.8 across 5 years, with a median of $375000.0 in 2022.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes soared 828.97% — and 2025, when it slumped 366.83%.
- Lantheus Holdings' Other Working Capital Changes stood at $2.8 million in 2022, then surged by 78.43% to $4.9 million in 2023, then slumped by 163.19% to -$3.1 million in 2024, then surged by 69.79% to -$938000.0 in 2025, then surged by 126.01% to $244000.0 in 2026.
- Business Quant data shows LNTH's Other Working Capital Changes at $84000.0 in Q1 2026, $3.0 million in Q4 2025, and -$2.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Lantheus Holdings | 6.54 Bn | 5.94 Bn | 241.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5.09 Mn |
| Jun 30, 2026 | -5.09 Mn |
| Jun 30, 2026 | -5.09 Mn |
| Mar 31, 2026 | 244,000.00 |
| Mar 31, 2026 | 244,000.00 |
| Mar 31, 2026 | 244,000.00 |
| Dec 31, 2025 | -938,000.00 |
| Dec 31, 2025 | -938,000.00 |
| Dec 31, 2025 | -938,000.00 |
| Sep 30, 2025 | 4.43 Mn |
| Sep 30, 2025 | 4.43 Mn |
| Sep 30, 2025 | 4.43 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Jun 30, 2025 | 1.39 Mn |
| Mar 31, 2025 | 528,000.00 |
| Mar 31, 2025 | 528,000.00 |
| Mar 31, 2025 | 528,000.00 |
| Dec 31, 2024 | -3.11 Mn |
| Dec 31, 2024 | -3.11 Mn |